Novel sulfonamides

Details for Australian Patent Application No. 2006283619 (hide)

Owner Allergan, Inc.

Inventors Burk, Robert M.

Agent Davies Collison Cave

Pub. Number AU-B-2006283619

PCT Pub. Number WO2007/024611

Priority 60/710,719 22.08.05 US; 11/426,482 26.06.06 US

Filing date 17 August 2006

Wipo publication date 1 March 2007

Acceptance publication date 12 July 2012

International Classifications

C07C 311/06 Amides of sulfonic acids, i.e. compounds having singly-bound oxygen atoms of sulfo groups replaced by nitrogen atoms, not being part of nitro or nitroso groups

A61K 31/20

A61K 31/23

A61P 27/06 Drugs for disorders of the senses

Event Publications

13 March 2008 PCT application entered the National Phase

  PCT publication WO2007/024611 Priority application(s): WO2007/024611

12 July 2012 Application Accepted

  Published as AU-B-2006283619

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006283620-8-substituted benzoazepines as Tolllike receptor modulators

2006283616-Networking through electronic messaging and mail